Publications

Dengue virus vaccine development

Yauch LE, Shresta S

The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus

Chen HW, King K, Tu J, Sanchez M, Luster AD, Shresta S

Role of humoral versus cellular responses induced by a protective dengue vaccine candidate

Zellerger RM, Miller R, Eddy WE, White LJ, Johnston RE, Shresta S

Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses

Chen HW, Cheng JX, Liu MT, King K, Peng JY, Zhang XQ, Wang CH, Shresta S, Schooley RT, Liu YT

An iminosugar with potent inhibition of dengue virus infection in vivio

Perry ST, Buck MD, Plummer EM, Penmasta RA, Batra H, Stavale EJ, Warfield KL, Dwek RA, Butters TD, Alonzi DS, Lada SM, King K, Klose B, Ramstedt U, Shresta S

Tracking the evolution of dengue virus strains D2S10 and D2S20 by 454 pyrosequencing

Makhluf H, Buck MD, King K, Perry ST, Henn MR, Shresta S

Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice

Prestwood TR, Morar MM, Zellweger RM, Miller R, May MM, Yauche LE, Lada SM, Shresta S

Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice

Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S

Role of complement in dengue virus infection: protection or pathogenesis?

Shresta S

Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a high conserved sequence

Stein DA, Perty ST, Buck MD, Oehmen CS, Fischer MA, Poore E, Smith JL, Lancaster AM, Hirsch AJ, Slifka MK, Nelson JA, Shresta S, Fruh K